We want to identify really useful peptides that can be leveraged and advanced as treatment for human diseases for which there is no solution at the moment. One potential prospect is MOTs-C, which Cohen discovered and has studied in Phase 1A and Phase 1B trials
It was time for an updated video on this topic the prior one is from like 2012 and my camera gear has come along way since then
This certificate verifies the chemical purity and content of the peptides, ensuring full transparency and safety in research
Clinical Update 2/09/2026 Coffee, Tea & Dementia Risk A study showed a reduced risk of cognitive decline and dementia with coffee consumption, but not with all types and amounts of coffee
The clinical data in humans doesnt exist yet
Research models use it to study acute GH axis responses, and it is often paired with a GHRP such as Ipamorelin, which triggers pulses against the elevated GHRH tone.